AstraZeneca files for US approval of drug to prevent Covid-19

AstraZeneca said on Tuesday it had submitted a request with US health regulators to grant emergency use authorisation for a new treatment to prevent Covid-19.

Also read: AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial

The British drugmaker had said in August that the treatment, an antibody therapy called AZD7442, had reduced the risk of people developing any Covid-19 symptoms by 77 per cent in a late-stage trial.